PO.TB08.01 · 肿瘤生物学

揭示轴突导向分子Netrin-1的一种新的ECM硬化功能

Unraveling a new ECM stiffening function of the axon guidance molecule Netrin-1

海报缩略图:揭示轴突导向分子Netrin-1的一种新的ECM硬化功能
编号 7489 展板 7 时间 4/22 09:00–12:00 区域 Section 30 主讲 Gaëtan Thivolle Lioux, MS
分会场 Tumor Adhesion
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Gaëtan THIVOLLE LIOUX, Laurent Fattet, PATRICK MEHLEN

Cancer Research Center of Lyon, Lyon, France

摘要 Abstract

中文摘要
研究现状 细胞外基质(ECM)是由核心结构蛋白和基质组相关成分组成的复杂而动态的网络。在生理条件下,ECM稳态有助于维持天然组织硬度。然而,这种平衡的破坏可导致异常硬化,这是包括纤维化和癌症在内的多种病理状况中观察到的标志。我们实验室研究依赖性受体配体Netrin-1(NTN1)的作用,这是一种主要在早期发育阶段表达的神经元导向蛋白。有趣的是,NTN1在肿瘤中频繁重新表达,其存在与ECM硬度增加相关。因此,我们的研究旨在阐明NTN1在ECM重塑和硬化中的作用。 方法与结果 使用原子力显微镜(AFM)在惰性Matrigel基质上,我们观察到补充重组Netrin-1(rNTN1)后硬度显著增加。这种硬化效应被NP137(一种靶向NTN1的单克隆抗体)逆转。通过对laminin-111和rNTN1的免疫荧光染色以及扫描电子显微镜(SEM)进行的结构分析,揭示了rNTN1存在时孔径显著减小。使用PEPPI软件进行的补充计算机分析表明NTN1与关键ECM成分(如Nidogen和Laminin)之间存在强相互作用。 展望 为验证这些预测的相互作用,我们用各种ECM蛋白进行了生物膜层干涉测量。此外,暴露于NTN1的MCF10A正常乳腺上皮细胞的3D培养模型显示出向更间充质和侵袭状态的表型转变。有趣的是,敲低NTN1受体并未阻止这种表型转变,提示NTN1通过直接调节ECM硬度促进细胞侵袭性存在一种新的受体非依赖性功能。目前正在对有或无内源性Netrin-1表达的成纤维细胞来源基质进行结构分析,以评估其对collagen IV和纤连蛋白网络的潜在重塑效应。同时,利用多种实验方法,这些基质被用于功能测定,以研究Netrin-1的ECM影响如何影响细胞行为和转录活性。
查看英文原文 English abstract
State of the art The extracellular matrix (ECM) is a complex and dynamic network composed of core structural proteins and matrisome-associated components. Under physiological conditions, ECM homeostasis contributes to the maintenance of natural tissue stiffness. However, disruption of this balance can lead to abnormal stiffening, a hallmark observed in various pathological conditions, including fibrosis and cancer. Our laboratory investigates the role of the dependence receptor ligand Netrin-1 (NTN1), a neuronal guidance protein predominantly expressed during early developmental stages. Intriguingly, NTN1 is frequently re-expressed in tumors, where its presence has been correlated with increased ECM stiffness. As such, our research aims to elucidate the role of NTN1 in ECM remodelling and stiffening. Methodology and resultsUsing atomic force microscopy (AFM) on inert Matrigel matrices, we observed a marked increase in stiffness upon supplementation with recombinant Netrin-1 (rNTN1). This stiffening effect was reversed by NP137, a monoclonal antibody targeting NTN1. Structural analyses via immunofluorescence staining for laminin-111 and rNTN1, alongside scanning electron microscopy (SEM), revealed a significant reduction in pore size in the presence of rNTN1. Complementary in silico analysis using PEPPI software indicated strong interactions between NTN1 and key ECM components such as Nidogen and Laminin. PerspectivesTo validate these predicted interactions, we performed biolayer interferometry with various ECM proteins. Furthermore, 3D cultures models of MCF10A normal mammary epithelial cells exposed to NTN1 displayed a phenotypic transition toward a more mesenchymal and invasive state. Interestingly, knockdown of NTN1 receptors did not prevent this phenotypic shift, suggesting a novel receptor-independent function for NTN1 in promoting cell invasiveness through direct modulation of ECM stiffness. Ongoing structural analyses are being conducted on fibroblast-derived matrices, with and without endogenous Netrin-1 expression, to evaluate its potential remodeling effects on collagen IV and fibronectin networks. In parallel, these matrices are utilized in functional assays to investigate how Netrin-1 ECM impact, influences cellular behaviours and transcriptional activity, using a range of experimental approaches.
利益披露 Disclosure
G. Thivolle lioux, None.. L. Fattet, None. P. Mehlen, Netris Pharma g., Board of Directors, non-salaried role), Stock, ), Patent.

← 返回 AACR 2026 检索